Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Aurinia Pharmaceuticals Inc. | 78,733 | reported | 18 May 2023 | tx 8+93,425−8,733 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 28,772 | reported | 07 May 2021 | tx 99+204,059−178,290 |
| Amylyx Pharmaceuticals, Inc. | 24,372 | reported | 04 Jun 2026 | tx 20+934,497−887,365 |
| BTHC VI Inc | 15,000 | reported | 16 Jun 2011 | tx 17+2,550,000 |
| METTLER TOLEDO INTERNATIONAL INC/ | 0 | reported | 22 Feb 2016 | tx 67+75,674−64,704 |
| MEDIMMUNE INC /DE | 0 | reported | 18 Jun 2007 | tx 4+25,000−85,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 04 Jun 2026 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 24,372 | 0.00 USD | deriv |
| 12 Jan 2026 | GIFT | Amylyx Pharmaceuticals, Inc. | 17,780 | 0.00 USD | |
| 05 Jun 2025 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 24 Jan 2025 | GIFT | Amylyx Pharmaceuticals, Inc. | 27,910 | 0.00 USD | |
| 03 Sept 2024 | PURCHASE | Amylyx Pharmaceuticals, Inc. | 100,000 | 2.20 USD | first after silence |
| 06 Jun 2024 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 25 Jan 2024 | GIFT | Amylyx Pharmaceuticals, Inc. | 9,100 | 0.00 USD | |
| 16 Jan 2024 | GIFT | Amylyx Pharmaceuticals, Inc. | 94,350 | 0.00 USD | |
| 08 Jun 2023 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 16,985 | 0.00 USD | deriv |
| 18 May 2023 | EXERCISE | Aurinia Pharmaceuticals Inc. | 8,733 | — | |
| 18 May 2023 | EXERCISE | Aurinia Pharmaceuticals Inc. | 8,733 | 0.00 USD | deriv |
| 16 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 33,084 | 31.86 USD | |
| 16 Mar 2023 | SALE | Amylyx Pharmaceuticals, Inc. | 1,916 | 32.45 USD | |
| 02 Mar 2023 | PURCHASE | Aurinia Pharmaceuticals Inc. | 20,000 | 8.91 USD | |
| 06 Jan 2022 | CONVERSION | Amylyx Pharmaceuticals, Inc. | 689,425 | — | |
| 29 Dec 2022 | GIFT | Amylyx Pharmaceuticals, Inc. | 13,800 | 0.00 USD | |
| 06 Jan 2022 | CONVERSION | Amylyx Pharmaceuticals, Inc. | 23,212 | 0.00 USD | deriv |
| 06 Jan 2022 | CONVERSION | Amylyx Pharmaceuticals, Inc. | 19,482 | 0.00 USD | deriv |
| 06 Jan 2022 | CONVERSION | Amylyx Pharmaceuticals, Inc. | 384,449 | 0.00 USD | deriv |
| 06 Jan 2022 | CONVERSION | Amylyx Pharmaceuticals, Inc. | 262,282 | 0.00 USD | deriv |
| 09 Jun 2022 | GRANT_AWARD | Amylyx Pharmaceuticals, Inc. | 19,000 | 0.00 USD | deriv |
| 18 May 2022 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 14,612 | 0.00 USD | deriv |
| 18 May 2022 | GRANT_AWARD | Aurinia Pharmaceuticals Inc. | 8,733 | 0.00 USD | deriv |
| 04 Mar 2022 | PURCHASE | Aurinia Pharmaceuticals Inc. | 5,000 | 10.82 USD | |
| 06 Jan 2022 | PURCHASE | Amylyx Pharmaceuticals, Inc. | 26,315 | 19.00 USD |
3 purchases reported after at least 12 months of silence — most recent on 03 Sept 2024.